Cargando…

Changes in Alternative Splicing as Pharmacodynamic Markers for Sudemycin D6

OBJECTIVE: The aim of the study was to define pharmacodynamic markers for sudemycin D6, an experimental cancer drug that changes alternative splicing in human blood. METHODS: Blood samples from 12 donors were incubated with sudemycin D6 for up to 24 hours, and at several time points total RNA from l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thurman, Morgan, van Doorn, Jacob, Danzer, Barbara, Webb, Thomas R, Stamm, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598794/ https://www.ncbi.nlm.nih.gov/pubmed/28932105 http://dx.doi.org/10.1177/1177271917730557

Ejemplares similares

Sudemycin E influences alternative splicing and changes chromatin modifications
por: Convertini, Paolo, et al.
Publicado: (2014)

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia
por: Xargay-Torrent, Sílvia, et al.
Publicado: (2015)

Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidates
por: Shi, Yihui, et al.
Publicado: (2015)

Determining the impact of alternative splicing events on transcriptome dynamics
por: Wilhelm, Emmanuelle, et al.
Publicado: (2008)

Alternative Spliced Transcripts as Cancer Markers
por: Caballero, Otavia L., et al.
Publicado: (2001)

Comprehensive analysis of mutually exclusive alternative splicing in C. elegans
por: Kuroyanagi, Hidehito, et al.
Publicado: (2014)

Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
por: Poh, Hui Xian, et al.
Publicado: (2022)

ASD: a bioinformatics resource on alternative splicing
por: Stamm, Stefan, et al.
Publicado: (2006)

Fine-Tuning of the Grain Size by Alternative Splicing of GS3 in Rice
por: Liu, Lei, et al.
Publicado: (2022)

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals
por: Schmid, Yasmin, et al.
Publicado: (2016)

Involvement of PARP1 in the regulation of alternative splicing
por: Matveeva, Elena, et al.
Publicado: (2016)

Alternative Splicing Generates Different 5′ UTRs in OCT4B Variants
por: Poursani, Ensieh M., et al.
Publicado: (2017)

Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene
por: Moon, Heegyum, et al.
Publicado: (2015)

C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1
por: Sumanasekera, Chiranthani, et al.
Publicado: (2012)

Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer
por: Wang, Qian, et al.
Publicado: (2019)

Alternative Splicing and DNA Damage Response in Plants
por: Nimeth, Barbara Anna, et al.
Publicado: (2020)

The interaction between prognostic and pharmacodynamic biomarkers
por: Bouranis, L, et al.
Publicado: (2013)

Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy
por: Hu, Ningyan, et al.
Publicado: (2023)

Cloning and characterization of a novel alternatively spliced transcript of the human CHD7 putative helicase
por: Colin, Christian, et al.
Publicado: (2010)

Evolution of Alternative Splicing Regulation: Changes in Predicted Exonic Splicing Regulators Are Not Associated with Changes in Alternative Splicing Levels in Primates
por: Irimia, Manuel, et al.
Publicado: (2009)

ZNF265—a novel spliceosomal protein able to induce alternative splicing
por: Adams, David J., et al.
Publicado: (2001)

SR proteins and the nonsense-mediated decay mechanism are involved in human GLB1 gene alternative splicing
por: Santamaria, Raül, et al.
Publicado: (2008)

Alternative Splicing and Its Impact as a Cancer Diagnostic Marker
por: Kim, Yun-Ji, et al.
Publicado: (2012)

Differential localization of HPV16 E6 splice products with E6-associated protein
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2005)

Pyrvinium pamoate changes alternative splicing of the serotonin receptor 2C by influencing its RNA structure
por: Shen, Manli, et al.
Publicado: (2013)

Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site
por: Tessier, Sarah J, et al.
Publicado: (2015)

Differential regulation of Cav2.2 channel exon 37 variants by alternatively spliced μ-opioid receptors
por: Gandini, Maria A., et al.
Publicado: (2019)

The Arabidopsis spliceosomal protein SmEb modulates ABA responses by maintaining proper alternative splicing of HAB1
por: Hong, Yechun, et al.
Publicado: (2021)

Oligonucleotide‐induced alternative splicing of serotonin 2C receptor reduces food intake
por: Zhang, Zhaiyi, et al.
Publicado: (2016)

Alternative Splice in Alternative Lice
por: Tovar-Corona, Jaime M., et al.
Publicado: (2015)

Splicing and alternative splicing in rice and humans
por: E, Zhiguo, et al.
Publicado: (2013)

Alternative Splicing of TAF6: Downstream Transcriptome Impacts and Upstream RNA Splice Control Elements
por: Kamtchueng, Catherine, et al.
Publicado: (2014)

Diverse alternative back-splicing and alternative splicing landscape of circular RNAs
por: Zhang, Xiao-Ou, et al.
Publicado: (2016)

The Oncogene Metadherin Interacts with the Known Splicing Proteins YTHDC1, Sam68 and T-STAR and Plays a Novel Role in Alternative mRNA Splicing
por: Luxton, Hayley J., et al.
Publicado: (2019)

Targeting alternative splicing by RNAi: from the differential impact on splice variants to triggering artificial pre-mRNA splicing
por: Fuchs, Armin, et al.
Publicado: (2021)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

Alternative splicing in cardiomyopathy
por: Beqqali, A.
Publicado: (2018)

Alternative Splicing in Angiogenesis
por: Bowler, Elizabeth, et al.
Publicado: (2019)

Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
por: Hu, Ningyan, et al.
Publicado: (2018)

The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes
por: Brunner, Martina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_50cnc12hcqlv7oa37io37e7tnd